An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Abstract: The pipelined-SAR ADC has become popular in wide-bandwidth and high-resolution applications due to its power-efficient architecture [1]. In the pursuit of higher ADC speeds while maintaining ...
Welcome to one of the most comprehensive and dynamic collections of Retrieval-Augmented Generation (RAG) tutorials available today. This repository serves as a hub for cutting-edge techniques aimed at ...